CPHI Milan 2026 will be held from 6–8 October 2026 at Fiera Milano, Italy, serving as a key venue for pharmaceutical professionals to network, source partners, and explore industry trends. Organizations that…

The global generic pharmaceutical industry plays a crucial role in healthcare, comprising over 90% of prescriptions in the U.S. and supplying around 20% of the world’s generics from India. These affordable drugs…

The oral solid dosage (OSD) forms—tablets, capsules, and granules—are essential to the global pharmaceutical market, dominating prescriptions due to their convenience and cost-effectiveness. However, the path to market for new products is…

In 2026, the US FDA’s approach to GMP inspections has drastically changed for pharmaceutical manufacturers in Bangalore. The agency is no longer using routine checklists but is instead employing AI-driven targeting systems…

The pharmaceutical industry is rapidly transforming, with manufacturers of tablets and capsules, especially in India, expanding their global presence and providing affordable medicines. However, success now hinges on strong quality systems, regulatory…

India’s clinical research landscape has transformed from a low-cost trial destination to a quality-focused R&D ecosystem, with the market valued at approximately USD 1.42 billion and expected to grow at a CAGR…

The global clinical research landscape is transforming, with sponsors, CROs, and research organizations adapting to evolving regulations and decentralized technologies by 2026. Operational excellence is essential as trials become data-driven and globally…

Ahmedabad, Gujarat Jul 15, 2026 (Issuewire.com)  – Zenovel: A Global Partner for Quality, Compliance, and Innovation in Life Sciences Beyond its impact on global health and economic growth, the pharmaceutical services sector powers innovation,…

Ahmedabad, Gujarat Jul 15, 2026 (Issuewire.com)  – Zenovel: A Global Partner for Quality, Compliance, and Innovation in Life Sciences Beyond its impact on global health and economic growth, the pharmaceutical services sector powers innovation,…

In clinical research, Glucagon-like peptide-1 (GLP-1) receptor agonists have gained significant attention for their transformative effects in diabetes treatment and notable efficacy in obesity and cardiovascular risk reduction, as well as potential…

Singapore has established itself as one of Asia’s leading destinations for clinical research and pharmaceutical innovation. With a robust healthcare infrastructure, internationally recognized research institutions, strong intellectual property protection, and a transparent…

  The regulatory affairs landscape is evolving faster than ever. As pharmaceutical, biotechnology, and medical device companies continue to expand globally, regulatory professionals are expected to manage increasingly complex submissions, comply with…

Artificial Intelligence (AI) is rapidly transforming the pharmaceutical industry. From drug discovery and clinical trial optimization to medical writing and regulatory operations, AI-driven technologies are becoming integral to modern healthcare innovation. However,…

The clinical research industry in Greece continues to attract pharmaceutical, biotechnology, and medical device companies seeking access to skilled healthcare professionals, research institutions, and a growing clinical trial ecosystem. As regulatory expectations…

Clinical trials are the foundation of pharmaceutical, biotechnology, and medical device innovation. However, even the most promising therapies can face significant delays or regulatory challenges if clinical trials are not monitored effectively….

Clinical trials have become increasingly complex, involving multiple sites, large volumes of data, decentralized trial models, and heightened regulatory expectations. Traditional monitoring approaches that rely heavily on 100% source data verification (SDV)…

Clinical trials have become increasingly complex. Sponsors face growing pressure to accelerate development timelines, manage multiple stakeholders, maintain regulatory compliance, and control costs while ensuring patient safety and data quality. Delays at…

Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), has posed significant challenges in oncology, with a five-year survival rate of approximately 13% and limited treatment options. The disease’s aggressive nature and resistance to…

Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), has posed significant challenges in oncology, with a five-year survival rate of approximately 13% and limited treatment options. The disease’s aggressive nature and resistance to…

Medical device innovation is advancing rapidly. From AI-powered diagnostic platforms to wearable monitoring technologies and implantable devices, manufacturers are bringing increasingly sophisticated products to market. However, innovation alone is not enough. Successful…